Merit Medical Systems, Inc. (NASDAQ: MMSI) has announced the appointment of Martha Aronson as the new President and Chief Executive Officer effective October 3, 2025. The company also stated that Fred P. Lampropoulos will continue to serve as Chairman of the Board, President, and CEO through this date.
In terms of financial performance, Merit Medical has reported preliminary unaudited revenue in the range of approximately $380 to $384 million for the quarter ended June 30, 2025. This represents a projected increase of approximately 12% to 14% compared to the revenue reported for the same quarter in 2024. The company also noted that the preliminary constant currency revenue for the quarter ended June 30, 2025, increased in the range of approximately 11% to 13% compared to the same period in the prior year.
Merit Medical Systems, Inc. is scheduled to release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. The investor conference call is set to take place on the same day at 5:00 p.m. Eastern Time.
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The company serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide. As a result of these announcements, the company's shares have moved -1.76% on the market, and are now trading at a price of $93.49. For more information, read the company's full 8-K submission here.
